文献速递认知障碍与痴呆

中年胰岛素抵抗、APOE基因型与晚年脑淀粉样蛋白沉积

Midlife insulin resistance, APOE genotype, and late-life brain amyloid accumulation.
PubMed 文献 · Neurology · 2018-02-23

该观察性研究纳入60名无痴呆老年志愿者,依据2000年HOMA-IR值分为胰岛素抵抗组(IR+,HOMA-IR>2.17,n=30)和对照组(IR-,HOMA-IR<1.25,n=30),两组APOE ε4携带者均占50%,于2014-2016年行[11C]匹兹堡化合物B-PET成像。结果显示IR+组淀粉样蛋白阳性PET扫描比例为60.0%,IR-组为33.3%(OR 3.0,95%CI 1.1-8.9,p=0.04),且该风险增加见于APOE ε4携带者和非携带者。

要点

  • 中年胰岛素抵抗与晚年脑淀粉样蛋白沉积风险增加相关(OR 3.0,95%CI 1.1-8.9,p=0.04)。
  • IR+组淀粉样蛋白阳性PET扫描比例为60.0%,IR-组为33.3%。
  • 该风险增加见于APOE ε4携带者和非携带者。

核心结论

  • 中年胰岛素抵抗是无痴呆老年人脑淀粉样蛋白沉积的独立危险因素。

研究设计与样本

  • 观察性研究,纳入芬兰全国性人群健康2000研究中60名无痴呆老年志愿者(基线平均年龄55.4岁,随访时70.9岁,女性占55.5%),于2014-2016年行[11C]匹兹堡化合物B-PET成像。
  • 参与者依据2000年HOMA-IR值和APOE ε4基因型招募,IR+组为基线HOMA-IR>2.17者(n=30),IR-组为基线HOMA-IR<1.25者(n=30),两组APOE ε4携带者均占50%(n=15)。
  • 分析采用多变量逻辑回归和线性回归。

主要发现

  • 淀粉样蛋白阳性PET扫描见于IR-组的33.3%和IR+组的60.0%(OR 3.0,95%CI 1.1-8.9,p=0.04)。
  • 该风险增加见于APOE ε4携带者和非携带者。
  • 在多变量调整其他认知和代谢危险因素后,较高的中年(而非晚年)连续HOMA-IR与随访时更大的脑淀粉样蛋白负荷相关(β=0.11,95%CI 0.002-0.22,p=0.04)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To examine whether midlife insulin resistance is an independent risk factor for brain amyloid accumulation in vivo after 15 years, and whether this risk is modulated by APOE ε4 genotype. METHODS: This observational study examined 60 elderly volunteers without dementia (mean age at baseline 55.4 and at follow-up 70.9 years, 55.5% women) from the Finnish population-based, nationwide Health2000 study with [11C]Pittsburgh compound B-PET imaging in 2014-2016. The participants were recruited according to their homeostatic model assessment of insulin resistance (HOMA-IR) values in the year 2000, and their APOE ε4 genotype. The exposure group (IR+, n = 30) consisted of individuals with HOMA-IR >2.17 at baseline (highest tertile of the Health2000 study population), and the control group (IR-, n = 30) consisted of individuals with HOMA-IR <1.25 at baseline (lowest tertile). The groups were enriched for APOE ε4 carriers, resulting in 50% (n = 15) APOE ε4 carriers in both groups. Analyses were performed with multivariate logistic and linear regression. RESULTS: An amyloid-positive PET scan was found in 33.3% of the IR- group and 60.0% of the IR+ group (odds ratio 3.0, 95% confidence interval 1.1-8.9, p = 0.04). The increased risk was seen in carriers and noncarriers of APOE ε4 genotype. Higher midlife, but not late-life continuous HOMA-IR was associated with a greater brain amyloid burden at follow-up after multivariate adjustments for other cognitive and metabolic risk factors (β = 0.11, 95% confidence interval 0.002-0.22, p = 0.04). CONCLUSIONS: These results indicate that midlife insulin resistance is an independent risk factor for brain amyloid accumulation in elderly individuals without dementia.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Ekblad LL, Johansson J, Helin S, et al. Midlife insulin resistance, APOE genotype, and late-life brain amyloid accumulation. Neurology. 2018. PMID: 29476033. doi:10.1212/WNL.0000000000005214

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。